期刊文献+

原发性肝癌经切除术后联合动脉介入化疗栓塞术对患者血清学肿瘤标志物水平、生存质量的影响 被引量:5

Effect of transcatheter arterial chemoembolization after resection on serum tumor markers levels and quality of life in patients with primary hepatic carcinoma
下载PDF
导出
摘要 目的分析原发性肝癌(HCC)经切除术后联合肝动脉介入化疗栓塞术(TACE)对患者血清学肿瘤标志物水平、生存质量的影响。方法将我院2016年1月至2017年12月收治的90例HCC患者根据治疗方式分为对照组和观察组,各45例。两组均接受腹腔镜肝癌切除术治疗,观察组在术后1周联合TACE治疗。比较两组的治疗效果。结果术后1、2年,观察组患者的生存率高于对照组,复发率低于对照组(P<0.05)。T1时,观察组的CP评分、TBIL、ALT、AST水平均高于对照组(P<0.05)。治疗后,观察组患者的AFP、GPC3、CA19-9、TK1水平均低于对照组,QOL-LC评分均高于对照组(P<0.05)。结论HCC经切除术联合TACE可降低复发率,提高生存质量,虽短期内会对肝功能造成损伤,但整体效果显著。 Objective To analyze the effect of transcatheter arterial chemoembolization(TACE)after resection on serum tumor markers levels and quality of life in patients with primary hepatic carcinoma(HCC).Methods A total of 90 cases with HCC treated in our hospital from January 2016 to December 2017 were divided into control group and observation group according to the treatment method,with 45 cases in each group.The two groups were treated with laparoscopic hepatectomy,and the observation group was treated with TACE at 1 week after operation.The therapeutic effects of the two groups were compared.Results After 1 and 2 years,the survival rate of the observation group were higher than those of the control group,and the recurrence rate were lower than those of the control group(P<0.05).At T1,the CP score,TBIL,ALT and AST levels of the observation group were higher than those of the control group(P<0.05).After treatment,the levels of AFP,GPC3,CA19-9 and TK1 of the observation group were lower than those of the control group,and the QOL-LC scores were higher than those of the control group(P<0.05).Conclusion The TACE after resection in HCC can reduce the recurrence rate and improve the quality of life.Although it can damage the liver function in a short time,the overall effect is significant.
作者 王崇宝 高娜 WANG Chongbao;GAO Na(Shaanxi Traditional Chinese Medicine Hospital,Xi'an 710003,China)
机构地区 陕西省中医医院
出处 《临床医学研究与实践》 2020年第30期18-20,共3页 Clinical Research and Practice
基金 陕西省2020年重点研发计划项目(No.2020SF-067)。
关键词 原发性肝癌 肝动脉化疗栓塞 血清肿瘤标志物 primary hepatic carcinoma transcatheter arterial chemoembolization serum tumor markers
  • 相关文献

参考文献10

二级参考文献134

  • 1王树声,张振权,黄天壬,杨宏徽,黄志雄,刘启福,雷一鸣,董柏青,陆冠臣,陶立新.广西90年代初人口死亡原因抽样调查研究[J].广西预防医学,2005,11(3). 被引量:3
  • 2吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091. 被引量:11
  • 3Marrero J, Romano P. GP73, a resident Golgi glyooprotein, is a novel serum marker for hepatocellular carcinoma[J]. Hepatol, 2005,43(6) :1007-1012.
  • 4中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎诊断标准(20lo年版)[J].中西医结合肝病杂志,2010,21(2):121-122.
  • 5NCCN.2010NCCN肿瘤学临床实践指南[EB/OL].http://www.nccn-asia.org/cn/default.aspx,2012-04-20.
  • 6Kladney RD,Cui XY,Bulla GA,et al. Expression of GP73 ,a resi- dent golgi membrane protein,in viral and nonviral liver disease [J]. Hepatology,2002,35(6) :1431-1440.
  • 7Kladney RD, Bulla GA, Guo L, et al. GP73, a novel golgi-localized protein upregulated by viral infection[J]. Gene, 2000,249 (12) : 53-65.
  • 8Block TM,ComunaleMA,LowmanM,et al. Use of targeted gly- coproteomics to identify serum glycoproteins that correlate with liver cancerinwoodchucks and humans[J].ProcNatlAcad SciU S A,2005,102(3):779-784.
  • 9应越英. 肝细胞肝癌的病理学[M]//汤钊猷.原发性肝癌. 上海:科学技术出版社, 1981:115-46.
  • 10Koh C, Zhao X, Samala N, et al. AASLD clinical practice guide-lines: a critical review of scientific evidence and evolving recommendations[J]. Hepatology, 2013, 58(6): 2142-2152.

共引文献342

同被引文献66

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部